Cargando…
Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
PURPOSE: Filler injections for aesthetic purposes are very popular, but can have far-reaching and irreversible consequences. This report describes the course of a patient with devastating complications after glabellar hyaluronic acid injection, their pathomechanism, management and outcome. OBSERVATI...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858863/ https://www.ncbi.nlm.nih.gov/pubmed/35243152 http://dx.doi.org/10.1016/j.ajoc.2022.101407 |
_version_ | 1784654326561505280 |
---|---|
author | Davidova, Petra Müller, Michael Wenner, Yaroslava König, Clara Kenikstul, Ninel Kohnen, Thomas |
author_facet | Davidova, Petra Müller, Michael Wenner, Yaroslava König, Clara Kenikstul, Ninel Kohnen, Thomas |
author_sort | Davidova, Petra |
collection | PubMed |
description | PURPOSE: Filler injections for aesthetic purposes are very popular, but can have far-reaching and irreversible consequences. This report describes the course of a patient with devastating complications after glabellar hyaluronic acid injection, their pathomechanism, management and outcome. OBSERVATIONS: A healthy, 43-year-old woman underwent her first hyaluronic acid injection in the glabella and went blind on her left eye immediately thereafter. Massaging of the injection area and observation were performed, before she presented with swelling of the left forehead and upper lid, ptosis, complete ophthalmoplegia and blindness in our hospital. Immediate massaging of the globe and systemic therapy including acetylsalicylic acid, tinzaparin sodium and cortisone was initiated and hyaluronidase injections in the injection area were performed. In the further course, the patient developed necrotic and hemorrhagic skin and mucosal lesions, lagophthalmos, anterior and posterior segment ischemia and globe hypotonia with consecutive globe deformation. In the follow-up of 2.5 months, lid swelling, lagophthalmos and ptosis resolved and keratopathy improved but blindness, skin lesions and strabismus with reduced eye motility were still present and madarosis and early enophthalmos were detected. CONCLUSIONS AND IMPORTANCE: The outcome of ophthalmic artery occlusion after hyaluronic acid filler injection is poor. Sufficient knowledge about facial anatomy, the implementation of filler injections and the management of complications is essential for the practitioner. The patient should be clarified about potential and even rare risks of these procedures. |
format | Online Article Text |
id | pubmed-8858863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88588632022-03-02 Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection Davidova, Petra Müller, Michael Wenner, Yaroslava König, Clara Kenikstul, Ninel Kohnen, Thomas Am J Ophthalmol Case Rep Case Report PURPOSE: Filler injections for aesthetic purposes are very popular, but can have far-reaching and irreversible consequences. This report describes the course of a patient with devastating complications after glabellar hyaluronic acid injection, their pathomechanism, management and outcome. OBSERVATIONS: A healthy, 43-year-old woman underwent her first hyaluronic acid injection in the glabella and went blind on her left eye immediately thereafter. Massaging of the injection area and observation were performed, before she presented with swelling of the left forehead and upper lid, ptosis, complete ophthalmoplegia and blindness in our hospital. Immediate massaging of the globe and systemic therapy including acetylsalicylic acid, tinzaparin sodium and cortisone was initiated and hyaluronidase injections in the injection area were performed. In the further course, the patient developed necrotic and hemorrhagic skin and mucosal lesions, lagophthalmos, anterior and posterior segment ischemia and globe hypotonia with consecutive globe deformation. In the follow-up of 2.5 months, lid swelling, lagophthalmos and ptosis resolved and keratopathy improved but blindness, skin lesions and strabismus with reduced eye motility were still present and madarosis and early enophthalmos were detected. CONCLUSIONS AND IMPORTANCE: The outcome of ophthalmic artery occlusion after hyaluronic acid filler injection is poor. Sufficient knowledge about facial anatomy, the implementation of filler injections and the management of complications is essential for the practitioner. The patient should be clarified about potential and even rare risks of these procedures. Elsevier 2022-02-11 /pmc/articles/PMC8858863/ /pubmed/35243152 http://dx.doi.org/10.1016/j.ajoc.2022.101407 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Davidova, Petra Müller, Michael Wenner, Yaroslava König, Clara Kenikstul, Ninel Kohnen, Thomas Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
title | Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
title_full | Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
title_fullStr | Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
title_full_unstemmed | Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
title_short | Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
title_sort | ophthalmic artery occlusion after glabellar hyaluronic acid filler injection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858863/ https://www.ncbi.nlm.nih.gov/pubmed/35243152 http://dx.doi.org/10.1016/j.ajoc.2022.101407 |
work_keys_str_mv | AT davidovapetra ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection AT mullermichael ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection AT wenneryaroslava ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection AT konigclara ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection AT kenikstulninel ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection AT kohnenthomas ophthalmicarteryocclusionafterglabellarhyaluronicacidfillerinjection |